A phase II study of Gleevec [imatinib], idarubicin and cytarabine in patients with chronic myeloid leukemia in blast phase

Trial Profile

A phase II study of Gleevec [imatinib], idarubicin and cytarabine in patients with chronic myeloid leukemia in blast phase

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Dec 2005

At a glance

  • Drugs Imatinib (Primary) ; Cytarabine; Idarubicin
  • Indications Chronic myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top